FTO and coronary artery disorder: In addition, the m6A levels in peripheral blood mononuclear cells of CHD patients are significantly lower than that of the control group, and the expression levels of FTO, METTL14, and ALKBH5 in the CHD patients are also lower than those of the control group [81].